These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 38429642)

  • 1. The novel circRNA circ_0045881 inhibits cell proliferation and invasion by targeting mir-214-3p in triple-negative breast cancer.
    Ren J; Chen W; Zhou Y; Sun J; Jiang G
    BMC Cancer; 2024 Mar; 24(1):278. PubMed ID: 38429642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsa_circRNA_102229 facilitates the progression of triple-negative breast cancer via regulating the miR-152-3p/PFTK1 pathway.
    Du C; Zhang J; Zhang L; Zhang Y; Wang Y; Li J
    J Gene Med; 2021 Sep; 23(9):e3365. PubMed ID: 34031947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis.
    Shao G; Fan X; Zhang P; Liu X; Huang L; Ji S
    Cell Biol Toxicol; 2023 Oct; 39(5):2183-2205. PubMed ID: 35870038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.
    Li H; Xu W; Xia Z; Liu W; Pan G; Ding J; Li J; Wang J; Xie X; Jiang D
    Aging (Albany NY); 2021 Jan; 13(3):4522-4551. PubMed ID: 33495420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis.
    Zhou Y; Ma G; Peng S; Tuo M; Li Y; Qin X; Yu Q; Kuang S; Cheng H; Li J
    Thorac Cancer; 2021 Sep; 12(18):2427-2438. PubMed ID: 34324278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0062558 promotes growth, migration, and glutamine metabolism in triple-negative breast cancer by targeting the miR-876-3p/SLC1A5 axis.
    Yuan M; Zhang J; He Y; Yi G; Rong L; Zheng L; Zhan T; Zhou C
    Arch Gynecol Obstet; 2022 Nov; 306(5):1643-1655. PubMed ID: 35284960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA hsa_circ_0001785 inhibits the proliferation, migration and invasion of breast cancer cells in vitro and in vivo by sponging miR-942 to upregulate SOCS3.
    Li Z; Zheng J; Lin W; Weng J; Hong W; Zou J; Zhang T; Ye C; Chen Y
    Cell Cycle; 2020 Nov; 19(21):2811-2825. PubMed ID: 33054543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway.
    Shi Y; Liu C
    BMC Cancer; 2021 Nov; 21(1):1249. PubMed ID: 34800978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0001925 promotes malignant progression in triple-negative breast cancer via miR-1299/YY1 axis.
    Shen BJ; Yang YF; Zhang XX
    Thorac Cancer; 2023 Mar; 14(8):746-757. PubMed ID: 36754085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircRNA hsa_circ_0003528/miR-215 is considered a potential target for predictive prognosis and therapy for triple-negative breast cancer.
    Chang R; Yu H; Li S; Pan J
    Mol Biol Rep; 2024 Aug; 51(1):901. PubMed ID: 39126511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0041732 regulates tumor properties of triple-negative breast cancer cells by the miR-149-5p/FGF5 pathway.
    Li H; Yin H; Yan Y
    Int J Biol Markers; 2022 Jun; 37(2):178-190. PubMed ID: 35341378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA hsa_circ_0069117 suppresses proliferation and migration of osteosarcoma cells lines via miR-875-3p/PF4V1 axis.
    Zhang Z; Zhou L; Zhou S; Li X
    J Orthop Surg Res; 2022 Jan; 17(1):37. PubMed ID: 35062989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA circ-ERBB2 Elevates the Warburg Effect and Facilitates Triple-Negative Breast Cancer Growth by the MicroRNA 136-5p/Pyruvate Dehydrogenase Kinase 4 Axis.
    Huang Y; Zheng S; Lin Y; Ke L
    Mol Cell Biol; 2021 Sep; 41(10):e0060920. PubMed ID: 34370552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The investigation of circRNA profiling reveals the regulatory role of the hsa_circ_0000375/miR-7706 pathway in breast cancer.
    Wang H; Liu F; Xue J; Liu Y; Gao W; Yang S; Mi Y; Zhang X; Gao S; Geng C
    Mol Biol Rep; 2023 Dec; 50(12):9993-10004. PubMed ID: 37904009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR-1343-3p/Bcl-3 axis through TGFβ/Smad3/EMT signaling.
    Ge P; Chen X; Liu J; Jing R; Zhang X; Li H
    Mol Carcinog; 2023 Jul; 62(7):1073-1085. PubMed ID: 37132942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circ-ZEB1 acts as an oncogene in triple negative breast cancer via sponging miR-448.
    Pei X; Zhang Y; Wang X; Xue B; Sun M; Li H
    Int J Biochem Cell Biol; 2020 Sep; 126():105798. PubMed ID: 32629026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa_circ_0097922 promotes tamoxifen resistance and cell malignant behaviour of breast cancer cells by regulating ACTN4 expression via miR-876-3p.
    Liang X; Liu X; Song Z; Zhu J; Zhang J
    Clin Exp Pharmacol Physiol; 2022 Dec; 49(12):1257-1269. PubMed ID: 35856314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircRNA hsa_circ_0006220 acts as a tumor suppressor gene by regulating miR-197-5p/CDH19 in triple-negative breast cancer.
    Shi Y; Han T; Liu C
    Ann Transl Med; 2021 Aug; 9(15):1236. PubMed ID: 34532373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hsa_circ_0000711 expression level on proliferation and apoptosis of hepatoma cells.
    Chen KH; Pan JF; Chen ZX; Pan D; Gao T; Huang M; Huang JN
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4161-4171. PubMed ID: 32373952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer.
    Zhang HD; Jiang LH; Hou JC; Zhong SL; Zhou SY; Zhu LP; Li J; Wang DD; Sun DW; Ji ZL; Tang JH
    Biomed Pharmacother; 2018 Nov; 107():1342-1353. PubMed ID: 30257349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.